For individuals battling Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a devastating condition, the introduction of this treatment and Tafamidis meglumine represents a significant change. These groundbreaking therapies preserve the transthyretin protein, halting its damaging build-up and alleviating the burden of the disease . People are now s… Read More